Multi-modal data drives our differentiation

Tempus is helping transform drug discovery by breaking down information silos to link together clinical, DNA, RNA, and whole slide pathology imaging data modalities. With this structured data, we can power AI and machine learning approaches to help accelerate drug development for patients.

4M+

de-identified* research records

to power large real-world evidence studies

1M+

records

with imaging data

500K+

records

with matched clinical and genomic data to understand driver mutations and outcomes associations

*Numbers shown indicate data as of June 2021.

Tempus is a leader in the field of personalized medicine, and like Genmab, Tempus has a mission to improve the lives of cancer patients. We are looking forward to expanding our exciting partnership with them and to the possibility of discovering important new oncology targets and biomarkers.

Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab

POWER YOUR INNOVATION AND DISCOVERY

Access Tempus data in multiple ways, to suit your research needs

TEMPUS LENS PLATFORM

Lens is a comprehensive, real-world, multi-modal data platform that enables Life Science companies to uncover new insights across the research and development spectrum. Top Pharma companies are using Lens to help them make smarter decisions, design more successful clinical trials, and bring molecules to market faster.

Lens empowers you to tackle your research and development needs:

  • Validate targets with one of the world’s largest multi-modal datasets
  • Characterize disease fully by analyzing co-expression or expression signatures
  • Design trials for precisely-defined patient populations
  • Bring your own models or work with our AI team to launch a multi-scale modeling approach

HOW WE PARTNER

Tempus View gives you near real time access to power your research initiatives. Interact with Tempus multi-modal data on-demand through an optimized cloud environment to help get the answers you need, when you need them.

Tempus Explore delivers speed, cost efficiency and deep domain expertise to help meet your research objectives. Derive insights from the full Tempus oncology database by leveraging Tempus bioinformatics experts.

Tempus Download offers a broad, typically multi-year relationship that supports numerous iterative research and development objectives that can span the lifecycle of your product. Get enterprise-wide access to Tempus multi-modal records by stakeholders across your organization in the indication(s) of your choice with this custom partnership model.

PARTNER WITH OUR AI EXPERTS

Inquire about collaboration opportunities with Tempus AI and Analytics Experts to support your drug development programs. We’ve established machine learning partnerships with numerous biopharmaceutical companies focused on areas such as:

  • Risk and response predictions with multi-modal input
  • Histogenomics – Image-based molecular biomarker predictions
  • Tumor microenvironment characterization

CASE STUDY TECH SPOTLIGHT

Target Discovery using Molecular Signatures of Pancreatic Ductal Adenocarcinoma (PDAC) with Tempus Data

Learn how our partners are using Tempus data to support target discovery.

Download Case Study